. 2016 Jul 29;5(1):1208. doi: 10.1186/s40064-016-2828-7

Table 1.

Basic information of the two groups

Group	Disease type [n (%)]					Cardiac dysfunction level III–IV [n(%)]	LVEF (%)
Group	SAP	UAP	STEMI	NSTEMI	UACHD	Cardiac dysfunction level III–IV [n(%)]	LVEF (%)
A (n = 306)	20 (6.5)	180 (58.8)	58 (19.0)	18 (5.9)	30 (9.8)	38 (12.4)	59.91 ± 8.63
B (n = 156)	10 (6.4)	90 (57.7)	42 (26.9)	8 (5.1)	6 (3.8)	16 (10.3)	60.32 ± 9.39
t/χ ²						1.681	1.854

Group	Previous history [n (%)]			LDL-C (mmol/L)	Fasting blood glucose (mmol/L)	eGFR [ml/(min 1.73 m²)]
Group	MI	Previous PCI	Old cerebral infarction	LDL-C (mmol/L)	Fasting blood glucose (mmol/L)	eGFR [ml/(min 1.73 m²)]
A (n = 306)	26 (8.5)	12 (3.9)	42 (13.7)	2.73 ± 1.07	6.25 ± 1.86	92.37 ± 19.38
B (n = 156)	6 (3.8)	6 (3.8)	12 (7.7)	2.68 ± 1.13	6.27 ± 2.01	92.20 ± 20.29
t/χ ²	3.466	0.002	3.644	0.557	0.088	0.279

Group	Age	Male [n (%)]	Other complications [n(%)]		Family history [(%)]	Smoking [n(%)]
Group	Age	Male [n (%)]	Diabetics	Hyperlipidemia	Family history [(%)]	Smoking [n(%)]
A (n = 306)	69.6 ± 10.6	164 (53.6)	82 (26.8)	124 (40.5)	94 (30.7)	122 (39.9)
B (n = 156)	69.5 ± 10.6	108 (69.2)^a	34 (21.8)	62 (39.7)	24 (15.4)^a	68 (43.6)
t/χ ²	0.307	8.265	2.302	0.031	14.439	0.591

Group	blood pressure levels	Medications
Group	blood pressure levels	Statin	ACEI or ARB	anti-platelet agents
A (n = 306)	149.3 ± 21.1	65 (21.2)	112 (36.6)	19 (55.2)
B (n = 156)	129.0 ± 12.4^a	31 (19.8)	11 (7.1)^a	77 (49.4)
t/χ ²	11.039	0.118	46.185	1.430

A: CHD-H group; B: CHD group

SAP stable angina pectoris, UAP unstable angina pectoris, UACHD untypical or asymptomatic CHD, OMI old myocardial infarction, STEMI acute ST-elevated myocardial infarction, NSTEMI non-ST-elevation acute myocardial infarction, LVEF left ventricular ejection fraction, eGFR estimated glomerular filtration rate, LDL-C low-density lipoprotein cholesterol, PCI percutaneous coronary within intervention

Compared with group A, ^a P < 0.01